NCT06185387

Brief Summary

Using color doppler U/S, Abdominal U/S and radioisotope to evaluate changes of renal morphology, function and doppler parameters post Percutaneous nephrolithotomy

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2024

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 12, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 29, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

December 29, 2023

Status Verified

December 1, 2023

Enrollment Period

Same day

First QC Date

November 12, 2023

Last Update Submit

December 27, 2023

Conditions

Renal Stone

Outcome Measures

Primary Outcomes (2)

  • Changes of renal function post percutaneous nephrolithotomy

    Radioisotope scan (DMSA scan) Split function in %

    3 months

  • Changes of renal doppler parameters after percutaneous nephrolithotomy.

    Measured by Resistive Index

    3 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with renal stones that are candidates for PCNL \>18 years old

You may qualify if:

  • Adult patients with age group ≥ 18 years old with renal stones candidate for PCNL.

You may not qualify if:

  • Patients with any previous intervention to extract the renal stones.
  • Patients with malrotated/anomalous kidney.
  • Patients with any grade of chronic kidney disease.
  • Patients with bleeding diathesis.
  • Patients who are unfit for surgery.
  • Pregnancy
  • Patients who are refusing the participation in our study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Nephrolithiasis

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

November 12, 2023

First Posted

December 29, 2023

Study Start

March 1, 2024

Primary Completion

March 1, 2024

Study Completion

May 1, 2025

Last Updated

December 29, 2023

Record last verified: 2023-12